Robeco Institutional Asset Management B.V. boosted its position in Teladoc Health, Inc. (NYSE:TDOC – Free Report) by 27.2% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 270,402 shares of the health services provider’s stock after buying an additional 57,741 shares during the quarter. Robeco Institutional Asset Management B.V. owned approximately 0.17% of Teladoc Health worth $7,003,000 at the end of the most recent quarter.
Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. EverSource Wealth Advisors LLC bought a new position in shares of Teladoc Health during the fourth quarter valued at approximately $25,000. Concord Wealth Partners acquired a new stake in Teladoc Health in the fourth quarter worth approximately $46,000. Harvest Fund Management Co. Ltd acquired a new stake in shares of Teladoc Health during the 4th quarter valued at $67,000. Covestor Ltd lifted its position in shares of Teladoc Health by 1,711.7% during the 1st quarter. Covestor Ltd now owns 1,087 shares of the health services provider’s stock valued at $78,000 after acquiring an additional 1,027 shares during the last quarter. Finally, Geneos Wealth Management Inc. lifted its position in shares of Teladoc Health by 215.5% during the 1st quarter. Geneos Wealth Management Inc. now owns 1,161 shares of the health services provider’s stock valued at $83,000 after acquiring an additional 793 shares during the last quarter. 81.81% of the stock is owned by institutional investors.
Teladoc Health Trading Down 5.3 %
Teladoc Health stock opened at $26.27 on Thursday. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.37 and a quick ratio of 3.25. The business’s fifty day moving average is $24.77 and its two-hundred day moving average is $25.99. Teladoc Health, Inc. has a 52 week low of $21.60 and a 52 week high of $42.69.
Wall Street Analyst Weigh In
A number of equities research analysts have recently commented on TDOC shares. Stephens started coverage on Teladoc Health in a research report on Tuesday, April 11th. They set an “equal weight” rating and a $25.00 price objective for the company. 888 reissued a “maintains” rating on shares of Teladoc Health in a research report on Friday, April 28th. VNET Group restated a “maintains” rating on shares of Teladoc Health in a research report on Thursday, April 27th. Deutsche Bank Aktiengesellschaft increased their target price on shares of Teladoc Health from $27.00 to $29.00 in a research report on Friday, April 28th. Finally, 58.com restated a “maintains” rating on shares of Teladoc Health in a report on Thursday, April 27th. One investment analyst has rated the stock with a sell rating, ten have assigned a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and an average target price of $30.81.
Check Out Our Latest Report on Teladoc Health
Insider Activity at Teladoc Health
In related news, CEO Jason N. Gorevic sold 10,000 shares of the company’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $30.03, for a total value of $300,300.00. Following the completion of the sale, the chief executive officer now owns 596,246 shares in the company, valued at $17,905,267.38. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. In other Teladoc Health news, insider Claus Torp Jensen sold 6,547 shares of the stock in a transaction dated Wednesday, July 26th. The stock was sold at an average price of $29.00, for a total value of $189,863.00. Following the completion of the sale, the insider now directly owns 13,096 shares in the company, valued at $379,784. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CEO Jason N. Gorevic sold 10,000 shares of the stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $30.03, for a total value of $300,300.00. Following the completion of the sale, the chief executive officer now owns 596,246 shares of the company’s stock, valued at $17,905,267.38. The disclosure for this sale can be found here. Over the last quarter, insiders sold 20,639 shares of company stock worth $588,119. 1.63% of the stock is owned by insiders.
Teladoc Health Profile
Teladoc Health, Inc provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.
Read More
- Five stocks we like better than Teladoc Health
- Understanding and Trading Breakout Stocks
- 5 Best Office REITs to Buy Now
- What is Insider Trading? What You Can Learn from Insider Trading
- Camping World Slashes its Dividend but Should You Cut the Stock?
- With Risk Tolerance, One Size Does Not Fit All
- SoFi Downgraded: Here’s How To Still Make Money
Want to see what other hedge funds are holding TDOC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teladoc Health, Inc. (NYSE:TDOC – Free Report).
Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.
